Effect of heme oxygenase-1 on renal function in rats with liver cirrhosis

World Journal of Gastroenterology

Volumn 17, Issue 3, 2011, Pages 322-328

  Guo, Shi Bin ^a   Duan, Zhi Jun ^a   Li, Qing ^a   Sun, Xiao Yu ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Bile duct ligation; Biliary cirrhosis; Carbon monoxide; Cobalt proto porphyrin; Heme oxygenase 1; Hepa torenal syndrome; Zinc protoporphyrin IX

Indexed keywords

ASPARTATE AMINOTRANSFERASE; HEME OXYGENASE 1; MESSENGER RNA; PROTOPORPHYRIN COBALT; PROTOPORPHYRIN ZINC; SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY BLOOD FLOW; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; CREATININE CLEARANCE; HEPATORENAL SYNDROME; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KIDNEY FUNCTION; LIVER CIRRHOSIS; LIVER NECROSIS; MALE; MEAN ARTERIAL PRESSURE; MESENCHYME; NONHUMAN; PATHOGENESIS; PORTAL VEIN BLOOD PRESSURE; PROTEIN EXPRESSION; RAT; RENAL ARTERY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SHAM PROCEDURE; SODIUM BLOOD LEVEL; SODIUM URINE LEVEL; URINE VOLUME; VASODILATATION;

EID: 79955761499     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v17.i3.322     Document Type: Article

References (34)

1. Miyazono M, Garat C, Morris KG Jr, Carter EP. Decreased renal heme oxygenase-1 expression contributes to decreased renal function during cirrhosis. Am J Physiol Renal Physiol 2002; 283: F1123-F1131
2. Guevara M, Ginès P. Hepatorenal syndrome. Dig Dis 2005; 23: 47-55
3. Meltzer J, Brentjens TE. Renal failure in patients with cirrhosis: hepatorenal syndrome and renal support strategies. Curr Opin Anaesthesiol 2010; 23: 139-144
4. Cárdenas A, Gines P. Hepatorenal syndrome. Clin Liver Dis 2006; 10: 371-385, ix-x
5. Moreau R, Lebrec D. Acute renal failure in patients with cirrhosis: perspectives in the age of MELD. Hepatology 2003; 37: 233-243
6. Cárdenas A. Hepatorenal syndrome: a dreaded complication of end-stage liver disease. Am J Gastroenterol 2005; 100: 460-467
7. Wadei HM, Mai ML, Ahsan N, Gonwa TA. Hepatorenal syndrome: pathophysiology and management. Clin J Am Soc Nephrol 2006; 1: 1066-1079
8. Martin PY, Ginès P, Schrier RW. Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis. N Engl J Med 1998; 339: 533-541
9. Türkay C, Yönem O, Arikan O, Baskin E. Nitric oxide and renal functions in liver cirrhosis. Turk J Gastroenterol 2004; 15: 73-76
10. Saracyn M, Wesołowski P, Nowak Z, Patera J, Kozłowski W, Wańkowicz Z. [Role of nitric oxide system in pathogenesis of experimental model of hepatorenal syndrome]. Pol Merkur Lekarski 2008; 24: 293-297
11. Islas-Carbajal MC, Covarrubias A, Grijalva G, Alvarez-Rodríguez A, Armendáriz-Borunda J, Rincón-Sánchez AR. Nitric oxide synthases inhibition results in renal failure improvement in cirrhotic rats. Liver Int 2005; 25: 131-140
12. Kozma F, Johnson RA, Zhang F, Yu C, Tong X, Nasjletti A. Contribution of endogenous carbon monoxide to regulation of diameter in resistance vessels. Am J Physiol 1999; 276: R1087-R1094
13. Kozma F, Johnson RA, Nasjletti A. Role of carbon monoxide in heme-induced vasodilation. Eur J Pharmacol 1997; 323: R1-R2
14. Maines MD. The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol 1997; 37: 517-554
15. Shimizu H, Takahashi T, Suzuki T, Yamasaki A, Fujiwara T, Odaka Y, Hirakawa M, Fujita H, Akagi R. Protective effect of heme oxygenase induction in ischemic acute renal failure. Crit Care Med 2000; 28: 809-817
16. Leung N, Croatt AJ, Haggard JJ, Grande JP, Nath KA. Acute cholestatic liver disease protects against glycerol-induced acute renal failure in the rat. Kidney Int 2001; 60: 1047-1057
17. Drummond GS. Control of heme metabolism by synthetic metalloporphyrins. Ann N Y Acad Sci 1987; 514: 87-95
18. Amersi F, Buelow R, Kato H, Ke B, Coito AJ, Shen XD, Zhao D, Zaky J, Melinek J, Lassman CR, Kolls JK, Alam J, Ritter T, Volk HD, Farmer DG, Ghobrial RM, Busuttil RW, Kupiec-Weglinski JW. Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury. J Clin Invest 1999; 104: 1631-1639
19. Fallon MB, Abrams GA, McGrath JW, Hou Z, Luo B. Common bile duct ligation in the rat: a model of intrapulmonary vasodilatation and hepatopulmonary syndrome. Am J Physiol 1997; 272: G779-G784
20. Luo B, Abrams GA, Fallon MB. Endothelin-1 in the rat bile duct ligation model of hepatopulmonary syndrome: correlation with pulmonary dysfunction. J Hepatol 1998; 29: 571-578
21. Wei CL, Lee KH, Khoo HE, Hon WM. Expression of haem oxygenase in cirrhotic rat liver. J Pathol 2003; 199: 324-334
22. Remmele W, Stegner HE. [Recommendation for uniform defnition of an immunoreactive score (IRS) for immunohis-tochemical estrogen receptor detection (ER-ICA) in breast cancer tissue]. Pathologe 1987; 8: 138-140
23. da Silva JL, Zand BA, Yang LM, Sabaawy HE, Lianos E, Abraham NG. Heme oxygenase isoform-specific expression and distribution in the rat kidney. Kidney Int 2001; 59: 1448-1457
24. Arroyo V, Fernandez J, Ginès P. Pathogenesis and treatment of hepatorenal syndrome. Semin Liver Dis 2008; 28: 81-95
25. Morita T, Perrella MA, Lee ME, Kourembanas S. Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. Proc Natl Acad Sci USA 1995; 92: 1475-1479
26. Christodoulides N, Durante W, Kroll MH, Schafer AI. Vascular smooth muscle cell heme oxygenases generate guanylyl cyclase-stimulatory carbon monoxide. Circulation 1995; 91: 2306-2309
27. Verma A, Hirsch DJ, Glatt CE, Ronnett GV, Snyder SH. Carbon monoxide: a putative neural messenger. Science 1993; 259: 381-384
28. Schraufnagel DE, Kay JM. Structural and pathologic changes in the lung vasculature in chronic liver disease. Clin Chest Med 1996; 17: 1-15
29. Hervé P, Lebrec D, Brenot F, Simonneau G, Humbert M, Sitbon O, Duroux P. Pulmonary vascular disorders in portal hypertension. Eur Respir J 1998; 11: 1153-1166
30. Chang SW, Ohara N. Pulmonary circulatory dysfunction in rats with biliary cirrhosis. An animal model of the hepatopul-monary syndrome. Am Rev Respir Dis 1992; 145: 798-805
31. Naik JS, O'Donaughy TL, Walker BR. Endogenous carbon monoxide is an endothelial-derived vasodilator factor in the mesenteric circulation. Am J Physiol Heart Circ Physiol 2003; 284: H838-H845
32. Carter EP, Hartsfeld CL, Miyazono M, Jakkula M, Morris KG Jr, McMurtry IF. Regulation of heme oxygenase-1 by nitric oxide during hepatopulmonary syndrome. Am J Physiol Lung Cell Mol Physiol 2002; 283: L346-L353
33. Bomzon A, Holt S, Moore K. Bile acids, oxidative stress, and renal function in biliary obstruction. Semin Nephrol 1997; 17: 549-562
34. Rodriguez F, Kemp R, Balazy M, Nasjletti A. Effects of exogenous heme on renal function: role of heme oxygenase and cyclooxygenase. Hypertension 2003; 42: 680-684